Amgen secures FDA approval for LUMAKRAS in KRAS G12C-mutated lung cancer treatment

In a significant development for cancer treatment, Amgen has achieved accelerated approval from the U.S. Food and Drug Administration (FDA) for its drug LUMAKRAS (sotorasib), ... Read More